Metabolic oligosaccharide engineering as a tool for glycobiology

Current Opinion in Chemical Biology

Volumn 7, Issue 5, 2003, Pages 616-625

  Dube, Danielle H ^a   Bertozzi, Carolyn R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; GLYCOPROTEIN; KETONE; MONOSACCHARIDE; OLIGOSACCHARIDE; PROTEOME; SIALIC ACID; URIDINE DIPHOSPHATE;

BIOLOGY; BIOSYNTHESIS; CATABOLISM; CATALYSIS; CELL SURFACE; CHEMICAL MODIFICATION; EUKARYOTE; GLYCOSYLATION; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS DUCREYI; METABOLIC ENGINEERING; POLYMERIZATION; PRECURSOR; PROTEOMICS; REVIEW; TECHNIQUE; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); EUKARYOTA; HAEMOPHILUS; HAEMOPHILUS DUCREYI; NEGIBACTERIA;

EID: 0142199949     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2003.08.006     Document Type: Review

References (46)

1. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A.et al. The sequence of the human genome. Science. 291:2001;1304-1351.
2. Rudd P.M., Elliott T., Cresswell P., Wilson I.A., Dwek R.A. Glycosylation and the immune system. Science. 291:2001;2370-2376.
3. Ghosh P., Dahms N.M., Kornfeld S. Mannose-6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 4:2003;202-213.
4. Wells L., Vosseller K., Hart G.W. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 291:2001;2376-2378.
5. Bertozzi C.R., Kiessling L.L. Chemical glycobiology. Science. 291:2001;2357-2364.
6. Seeberger P.H., Haase W.C. Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries. Chem Rev. 100:2000;4349-4394.
7. Sears P., Wong C.H. Toward automated synthesis of oligosaccharides and glycoproteins. Science. 291:2001;2344-2350.
8. Saxon E., Bertozzi C.R. Chemical and biological strategies for engineering cell surface glycosylation. Annu Rev Cell Dev Biol. 17:2001;1-23 This review provides an overview of strategies to manipulate cell surface glycans. These include glycosyltransferase or glycosidase gene knockouts, small-molecule inhibitors of glycan-processing enzymes, and chemical and enzymatic cell surface remodeling.
9. Goon S., Bertozzi C.R. Metabolic substrate engineering as a tool for glycobiology. J Carbohydr Chem. 21:2002;943-977.
10. Tyrrell D., James P., Rao N., Foxall C., Abbas S., Dasgupta F., Nashed M., Hasegawa A., Kiso M., Asa D.et al. Structural requirements for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci USA. 88:1991;10372-10376.
11. Powell L.D., Sgroi D., Sjoberg E.R., Stamenkovic I., Varki A. Natural ligands of the B-cell adhesion molecule CD22-β carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition. J Biol Chem. 268:1993;7019-7027.
12. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 69:2000;531-569.
13. Kayser H., Zeitler R., Kannicht C., Grunow D., Nuck R., Reutter W. Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J Biol Chem. 267:1992;16934-16938.
14. Keppler O.T., Horstkorte R., Pawlita M., Schmidt C., Reutter W. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology. 11:2001;11R-18R This is an excellent and comprehensive review of the effects of unnatural sialic acids on biological processes such as viral binding and neurite outgrowth.
15. Keppler O.T., Stehling P., Herrmann M., Kayser H., Grunow D., Reutter W., Pawlita M. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem. 270:1995;1308-1314.
16. Wieser J.R., Heisner A., Stehling P., Oesch F., Reutter W. In vivo modulated N-acyl side chain of N-acetylneuraminic acid modulates the cell contact-dependent inhibition of growth. FEBS Lett. 395:1996;170-173.
17. Collins B.E., Fralich T.J., Itonori S., Ichikawa Y., Schnaar R.L. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. Glycobiology. 10:2000;11-20 The results of this paper suggest that sialic acid plays a role in the functions of the central nervous system.
18. Jacobs C.L., Goon S., Yarema K.J., Hinderlich S., Hang H.C., Chai D.H., Bertozzi C.R. Substrate specificity of the sialic acid biosynthetic pathway. Biochemistry. 40:2001;12864-12874.
19. Oetke C., Brossmer R., Mantey L.R., Hinderlich S., Isecke R., Reutter W., Keppler O.T., Pawlita M. Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem. 277:2002;6688-6695 This study significantly expands the structural modifications that are possible to engender in cell surface sialic acids. The breakthrough is to bypass the bottleneck step in the pathway, ManNAc 6-kinase, by feeding analogs of sialic acid rather than ManNAc.
20. Schilling B., Goon S., Samuels N.M., Gaucher S.P., Leary J.A., Bertozzi C.R., Gibson B.W. Biosynthesis of sialylated lipooligosaccharides in Haemophilis ducreyi is dependent on exogenous sialic acid and not mannosamine. Incorporation studies using N-acylmannosamine analogues, N-glycolylneuraminic acid, and C-13-labeled N-acetylneuraminic acid. Biochemistry. 40:2001;12666-12677.
21. Goon S., Schilling B., Tullius M.V., Gibson B.W., Bertozzi C.R. Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides. Proc Natl Acad Sci USA. 100:2003;3089-3094 This is the first example of biosynthetic modulation of sialic acid in bacteria.
22. Mahal L.K., Charter N.W., Angata K., Fukuda M., Koshland D.E. Jr., Bertozzi C.R. A small-molecule modulator of poly-α-2,8-sialic acid expression on cultured neurons and tumor cells. Science. 294:2001;380-382 This paper demonstrates that PSA can be selectively disrupted by a metabolic inhibitor, ManNBut, without detectable effects on the expression of other forms of sialic acid. This offers a tool to study the functions of PSA in vivo.
23. Charter N.W., Mahal L.K., Koshland D.E. Jr., Bertozzi C.R. Differential effects of unnatural sialic acids on the polysialylation of the neural cell adhesion molecule and neuronal behavior. J Biol Chem. 277:2002;9255-9261.
24. Buttner B., Kannicht C., Schmidt C., Loster K., Reutter W., Lee H.Y., Nohring S., Horstkorte R. Biochemical engineering of cell surface sialic acids stimulates axonal growth. J Neurosci. 22:2002;8869-8875.
25. Hang H.C., Bertozzi C.R. Chemoselective approaches to glycoprotein assembly. Acc Chem Res. 34:2001;727-736.
26. Mahal L.K., Yarema K.J., Bertozzi C.R. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science. 276:1997;1125-1128.
27. Yarema K.J., Mahal L.K., Bruehl R.E., Rodriguez E.C., Bertozzi C.R. Metabolic delivery of ketone groups to sialic acid residues - application to cell surface glycoform engineering. J Biol Chem. 273:1998;31168-31179.
28. Hang H.C., Bertozzi C.R. Ketone isosteres of 2-N-acetamidosugars as substrates for metabolic cell surface engineering. J Am Chem Soc. 123:2001;1242-1243 This paper demonstrates that the GalNAc salvage pathway can be exploited for metabolic oligosaccharide engineering.
29. Sadamoto R., Niikura K., Sears P.S., Liu H.T., Wong C.H., Suksomcheep A., Tomita F., Monde K., Nishimura S.I. Cell-wall engineering of living bacteria. J Am Chem Soc. 124:2002;9018-9019 This is the first report of the introduction of bio-orthogonal functional groups into bacterial cell walls using biosynthetic mechanisms. The work may have applications in vaccine development or cell targeting.
30. Saxon E., Bertozzi C.R. Cell surface engineering by a modified Staudinger reaction. Science. 287:2000;2007-2010 This paper introduces the Staudinger ligation as a novel chemistry for cell surface modification.
31. Saxon E., Luchansky S.J., Hang H.C., Yu C., Lee S.C., Bertozzi C.R. Investigating cellular metabolism of synthetic azidosugars with the Staudinger ligation. J Am Chem Soc. 124:2002;14893-14902.
32. Vocadlo D.J., Hang H.C., Kim E.-J., Hanover J.A., Bertozzi C.R. A chemical approach for identifying O-GlcNAc modified proteins in cells. Proc Natl Acad Sci USA. 100:2003;9116-9121 This paper demonstrates that the GlcNAc salvage pathway is tolerant of unnatural azido-GlcNAc analogs, resulting in their incorporation into O-GlcNAc-modified proteins. This provides a means to selectively tag the modified proteins for proteomics analysis.
33. Hakomori S., Zhang Y. Glycosphingolipid antigens and cancer therapy. Chem Biol. 4:1997;97-104.
34. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta. 1473:1999;21-34.
35. Fukuda M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56:1996;2237-2244.
36. Kelm S., Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol. 175:1997;137-240.
37. Mahal LK, Yarema KJ, Lemieux GA, Bertozzi CR: Chemical approaches to glycobiology: engineering cell surface sialic acids for tumor targeting. In Sialobiology and Other Novel Forms of Glycosylation. Inoue Y, Lee YC, Troy FA III, Eds. Osaka, Japan: Gakushin Publishing Company; 1999:273-280.
38. Lemieux G.A., Yarema K.J., Jacobs C.L., Bertozzi C.R. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents. J Am Chem Soc. 121:1999;4278-4279.
39. Nauman D.A., Bertozzi C.R. Kinetic parameters for small-molecule drug delivery by covalent cell surface targetting. Biochim Biophys Acta. 1568:2001;147-154.
40. Liu T.M., Guo Z.W., Yang Q.L., Sad S., Jennings H.J. Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells. J Biol Chem. 275:2000;32832-32836 This is the first report on the use of unnatural sialic acid biosynthesis for tumor immunotherapy. The results suggest that unnatural mannosamine precursors are converted to sialic acids in animals and incorporated into cell surface glycans. In addition, the work demonstrates that the immune system can discriminate between natural glycans and their subtly modified variants induced by metabolic engineering.
41. Lemieux G.A., Bertozzi C.R. Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem Biol. 8:2001;265-275.
42. Yarema K.J., Goon S., Bertozzi C.R. Metabolic selection of glycosylation defects in human cells. Nat Biotechnol. 19:2001;553-558 This work uses metabolic oligosaccharide engineering as a tool to select for genetic defects that affect sialic acid metabolism. Mutant cell populations with defects in UDP-GlcNAc 2-epimerase were identified that share phenotypic qualities with cells from sialuria patients. The genetic mutations in both were found to be identical.
43. Keppler O.T., Hinderlich S., Langner J., Schwartz-Albiez R., Reutter W., Pawlita M. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science. 284:1999;1372-1376 This paper confirmed a primary role for UDP-GlcNAc 2-epimerase in the biosynthesis of sialic acid.
44. Luchansky S.J., Yarema K.J., Takahashi S., Bertozzi C.R. GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism. J Biol Chem. 278:2003;8035-8042 Metabolic oligosaccharide biosynthesis was used to probe the function of GlcNAc 2-epimerase. The work demonstrated that GlcNAc 2-epimerase serves a catabolic role in sialic acid metabolism, a purpose opposite to that of UDP-GlcNAc 2-epimerase.
45. Rostovtsev V.V., Green L.G., Fokin V.V., Sharpless K.B. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective 'ligation' of azides and terminal alkynes. Angew Chem Int Ed Engl. 41:2002;2596-2599 This report describes the development of a copper(I)-catalyzed 1,3-dipolar cycloaddition between azides and alkynes that proceeds readily under physiological conditions.
46. Speers A.E., Adam G.C., Cravatt B.F. Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3+2] cyloaddition. J Am Chem Soc. 125:2003;4686-4687 The authors utilized the titular reaction between azides and alkynes to tag azide-labeled proteins from tissue extracts. The technique was used for functional proteomics analysis with mechanism-based covalent inhibitors.